Clinical Trial

Cannabis Use Registry to Improve Overall Understanding of Symptoms (CURIOUS)

Study acronym: CURIOUS
Recruiting
View on ClinicalTrials.gov →
Summary
Through partnership with Ontracka, the HealthPartners Institute Cancer Research Center created a secure and compliant app-based technology with the ability to seamlessly collect patient-level data on symptoms, cannabis use, real-time response to cannabis consumption, and patient-reported changes in supportive care medications such as opioids and antiemetics. By joining this registry, patients will have access to expert cannabis education, dosing recommendations, and easy symptom tracking. Patients with cancer and their oncology clinicians can utilize this reliable, cancer-specific data to help them make informed decisions together about how cannabis could be incorporated into a treatment plan. To learn more and sign up, visit https://study.ontracka.com/cannabiscurious
Trial Details
NCT Number NCT07227324
Lead Sponsor HealthPartners Institute
Collaborators: Ontracka
Conditions Cannabis Use, Cancer
Enrollment 1,000 participants
Start Date 2025-08-26
Primary Completion 2027-04 (estimated)
Study Completion 2028-04 (estimated)
Updated on ClinicalTrials.gov 2025-11-12